Ashton Thomas Private Wealth’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-204
Closed -$28.1K 1382
2024
Q2
$28.1K Buy
+204
New +$28.1K ﹤0.01% 1062